{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:54:43Z","timestamp":1782744883085,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04097-y","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:00:48Z","timestamp":1741798848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic potential of microbiota modulation in psoriasis: current evidence and future directions"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2975-4525","authenticated-orcid":false,"given":"Ali Karimi","family":"Bakhshandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6785-7017","authenticated-orcid":false,"given":"Asal","family":"Minasazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0512-7193","authenticated-orcid":false,"given":"Omid","family":"Yeganeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-2181","authenticated-orcid":false,"given":"Mahdi","family":"Behi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"4097_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s40588-023-00213-6","author":"F SadeghpourHeravi","year":"2024","unstructured":"SadeghpourHeravi F (2024) Gut microbiota and autoimmune diseases: mechanisms, treatment, challenges, and future recommendations. Curr Clin Micro Rpt. https:\/\/doi.org\/10.1007\/s40588-023-00213-6","journal-title":"Curr Clin Micro Rpt"},{"key":"4097_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073831","author":"J Olejnik-Wojciechowska","year":"2024","unstructured":"Olejnik-Wojciechowska J et al (2024) The role of epigenetic factors in the pathogenesis of psoriasis. Multidiscip Digital Pub Inst. https:\/\/doi.org\/10.3390\/ijms25073831","journal-title":"Multidiscip Digital Pub Inst"},{"key":"4097_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119998","volume":"565","author":"O Yeganeh","year":"2025","unstructured":"Yeganeh O, Abdolahinia ED, Soofiyani SR, Faghfuri E, Shafie A, Pahlavan Y (2025) Biosensors for autoimmune diseases. Clin Chim Acta 565:119998. https:\/\/doi.org\/10.1016\/j.cca.2024.119998","journal-title":"Clin Chim Acta"},{"key":"4097_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2096995","author":"R Md.Mahmud","year":"2022","unstructured":"Md.Mahmud R et al (2022) Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2022.2096995","journal-title":"Gut Microbes."},{"issue":"3","key":"4097_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298443","volume":"19","author":"F Feng","year":"2024","unstructured":"Feng F, Li R, Tian R, Wu X, Zhang N, Nie Z (2024) The causal relationship between gut microbiota and immune skin diseases: a bidirectional Mendelian randomization. PLoS ONE 19(3):e0298443. https:\/\/doi.org\/10.1371\/journal.pone.0298443","journal-title":"PLoS ONE"},{"issue":"11","key":"4097_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103169","volume":"21","author":"B Kapoor","year":"2022","unstructured":"Kapoor B, Gulati M, Rani P, Gupta R (2022) Psoriasis: interplay between dysbiosis and host immune system. Autoimmun Rev 21(11):103169. https:\/\/doi.org\/10.1016\/j.autrev.2022.103169","journal-title":"Autoimmun Rev"},{"key":"4097_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083998","author":"I Olejniczak-Staruch","year":"2021","unstructured":"Olejniczak-Staruch I, Ci\u0105\u017cy\u0144ska M, Sobolewska-Sztychny D, Narbutt J, Skibi\u0144ska M, Lesiak A (2021) Alterations of the skin and gut microbiome in psoriasis and psoriatic arthritis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22083998","journal-title":"Int J Mol Sci."},{"issue":"2","key":"4097_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/medicina60020337","volume":"60","author":"M Tampa","year":"2024","unstructured":"Tampa M, Mitran MI, Mitran CI, Matei C, Georgescu SR (2024) Psoriasis: what is new in markers of disease severity? Medicina (B Aires) 60(2):337. https:\/\/doi.org\/10.3390\/medicina60020337","journal-title":"Medicina (B Aires)"},{"key":"4097_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1728253","author":"R Di Caprio","year":"2020","unstructured":"Di Caprio R, Caiazzo G, Cacciapuoti S, Fabbrocini G, Scala E, Balato A (2020) Safety concerns with current treatments for psoriasis in the elderly. Expert Opin Drug Saf. https:\/\/doi.org\/10.1080\/14740338.2020.1728253","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"4097_CR10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","volume":"82","author":"A Menter","year":"2020","unstructured":"Menter A et al (2020) Joint American academy of dermatology-national psoriasis foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol 82(6):1445\u20131486. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.044","journal-title":"J Am Acad Dermatol"},{"key":"4097_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713313","author":"HJ Lee","year":"2023","unstructured":"Lee HJ, Kim M (2023) Challenges and future trends in the treatment of psoriasis. Multidiscip Dig Pub Inst. https:\/\/doi.org\/10.3390\/ijms241713313","journal-title":"Multidiscip Dig Pub Inst"},{"key":"4097_CR12","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2023-0081","author":"Y Pahlavan","year":"2024","unstructured":"Pahlavan Y, Yeganeh O, Karami C (2024) \u2018Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach. Future Sci OA. https:\/\/doi.org\/10.2144\/fsoa-2023-0081","journal-title":"Future Sci OA"},{"key":"4097_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1448626","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Xu F, Chen H, Zheng Q (2024) The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2024.1448626","journal-title":"Front Med (Lausanne)"},{"key":"4097_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37432","volume-title":"Fecal microbiota transplantation for the treatment of chronic infl ammatory skin diseases","author":"M Wu","year":"2024","unstructured":"Wu M, Chen X, Lu Q, Yao X (2024) Fecal microbiota transplantation for the treatment of chronic infl ammatory skin diseases. Elsevier Ltd, New York. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37432"},{"key":"4097_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122612","volume":"345","author":"J Wang","year":"2024","unstructured":"Wang J, He M, Yang M, Ai X (2024) Gut microbiota as a key regulator of intestinal mucosal immunity. Life Sci 345:122612. https:\/\/doi.org\/10.1016\/j.lfs.2024.122612","journal-title":"Life Sci"},{"issue":"9","key":"4097_CR16","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.3390\/ijms21093303","volume":"21","author":"K Okada","year":"2020","unstructured":"Okada K, Matsushima Y, Mizutani K, Yamanaka K (2020) The role of gut microbiome in psoriasis: oral administration of staphylococcus aureus and streptococcus danieliae exacerbates skin inflammation of imiquimod-induced psoriasis-like dermatitis. Int J Mol Sci 21(9):3303. https:\/\/doi.org\/10.3390\/ijms21093303","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4097_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/jcm8071021","volume":"8","author":"M Sikora","year":"2019","unstructured":"Sikora M et al (2019) Intestinal fatty acid binding protein, a biomarker of intestinal barrier, is associated with severity of psoriasis. J Clin Med 8(7):1021. https:\/\/doi.org\/10.3390\/jcm8071021","journal-title":"J Clin Med"},{"issue":"1","key":"4097_CR18","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1038\/s41598-018-22125-y","volume":"8","author":"FM Codo\u00f1er","year":"2018","unstructured":"Codo\u00f1er FM et al (2018) Gut microbial composition in patients with psoriasis. Sci Rep 8(1):3812. https:\/\/doi.org\/10.1038\/s41598-018-22125-y","journal-title":"Sci Rep"},{"key":"4097_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.105970","volume":"175","author":"C Wen","year":"2023","unstructured":"Wen C, Pan Y, Gao M, Wang J, Huang K, Tu P (2023) Altered gut microbiome composition in nontreated plaque psoriasis patients. Microb Pathog 175:105970. https:\/\/doi.org\/10.1016\/j.micpath.2023.105970","journal-title":"Microb Pathog"},{"issue":"5","key":"4097_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176955","volume":"12","author":"H Eppinga","year":"2017","unstructured":"Eppinga H et al (2017) Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by dimethylfumarate therapy (DMF). PLoS ONE 12(5):e0176955. https:\/\/doi.org\/10.1371\/journal.pone.0176955","journal-title":"PLoS ONE"},{"issue":"4","key":"4097_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/lam.13630","volume":"74","author":"L Schade","year":"2022","unstructured":"Schade L et al (2022) The gut microbiota profile in psoriasis: a Brazilian case-control study. Lett Appl Microbiol 74(4):498\u2013504. https:\/\/doi.org\/10.1111\/lam.13630","journal-title":"Lett Appl Microbiol"},{"issue":"18","key":"4097_CR22","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.3390\/nu15183931","volume":"15","author":"G Bianchetti","year":"2023","unstructured":"Bianchetti G et al (2023) Unraveling the gut microbiome-diet connection: exploring the impact of digital precision and personalized nutrition on microbiota composition and host physiology. Nutrients 15(18):3931. https:\/\/doi.org\/10.3390\/nu15183931","journal-title":"Nutrients"},{"issue":"7","key":"4097_CR23","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/jocd.16299","volume":"23","author":"K Wei","year":"2024","unstructured":"Wei K et al (2024) Efficacy of probiotic supplementation in the treatment of psoriasis\u2014a systematic review and meta-analysis. J Cosmet Dermatol 23(7):2361\u20132367. https:\/\/doi.org\/10.1111\/jocd.16299","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"4097_CR24","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s12602-022-09981-x","volume":"15","author":"C Castro-L\u00f3pez","year":"2023","unstructured":"Castro-L\u00f3pez C, Romero-Luna HE, Garc\u00eda HS, Vallejo-Cordoba B, Gonz\u00e1lez-C\u00f3rdova AF, Hern\u00e1ndez-Mendoza A (2023) Key stress response mechanisms of probiotics during their journey through the digestive system: a review. Probiotics Antimicrob Proteins 15(5):1250\u20131270. https:\/\/doi.org\/10.1007\/s12602-022-09981-x","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4097_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00639","author":"S Omenetti","year":"2015","unstructured":"Omenetti S, Pizarro TT (2015) The Treg\/Th17 axis: a dynamic balance regulated by the gut microbiome. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2015.00639","journal-title":"Front Immunol."},{"issue":"12","key":"4097_CR26","doi-asserted-by":"publisher","first-page":"8925","DOI":"10.1002\/jcp.29737","volume":"235","author":"H Atabati","year":"2020","unstructured":"Atabati H et al (2020) Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: evidence from experimental and clinical studies. J Cell Physiol 235(12):8925\u20138937. https:\/\/doi.org\/10.1002\/jcp.29737","journal-title":"J Cell Physiol"},{"issue":"1","key":"4097_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13075-023-03118-3","volume":"25","author":"J Moon","year":"2023","unstructured":"Moon J et al (2023) Faecalibacterium prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis. Arthritis Res Ther 25(1):130. https:\/\/doi.org\/10.1186\/s13075-023-03118-3","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4097_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4049\/jimmunol.2300480","volume":"212","author":"K Han","year":"2024","unstructured":"Han K, Xu J, Xie F, Crowther J, Moon JJ (2024) Engineering strategies to modulate the gut microbiome and immune system. J Immunol 212(2):208\u2013215. https:\/\/doi.org\/10.4049\/jimmunol.2300480","journal-title":"J Immunol"},{"issue":"6","key":"4097_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.36849\/JDD.6237","volume":"21","author":"J Moludi","year":"2022","unstructured":"Moludi J et al (2022) Probiotics supplementation improves quality of life, clinical symptoms, and inflammatory status in patients with psoriasis. J Drugs Dermatol 21(6):637\u2013644. https:\/\/doi.org\/10.36849\/JDD.6237","journal-title":"J Drugs Dermatol"},{"key":"4097_CR30","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3305","author":"V Navarro-L\u00f3pez","year":"2019","unstructured":"Navarro-L\u00f3pez V et al (2019) Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized clinical trial. Acta Dermato Venereologica. https:\/\/doi.org\/10.2340\/00015555-3305","journal-title":"Acta Dermato Venereologica."},{"issue":"1","key":"4097_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053867","volume":"8","author":"T Levkovich","year":"2013","unstructured":"Levkovich T et al (2013) Probiotic bacteria induce a \u201cglow of health.\u201d PLoS ONE 8(1):e53867. https:\/\/doi.org\/10.1371\/journal.pone.0053867","journal-title":"PLoS ONE"},{"issue":"3","key":"4097_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004903","volume":"4","author":"F Hacini-Rachinel","year":"2009","unstructured":"Hacini-Rachinel F, Gheit H, Le Luduec J-B, Dif F, Nancey S, Kaiserlian D (2009) Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS ONE 4(3):e4903. https:\/\/doi.org\/10.1371\/journal.pone.0004903","journal-title":"PLoS ONE"},{"issue":"4","key":"4097_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/gmic.25487","volume":"4","author":"D Groeger","year":"2013","unstructured":"Groeger D et al (2013) Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 4(4):325\u2013339. https:\/\/doi.org\/10.4161\/gmic.25487","journal-title":"Gut Microbes"},{"issue":"6","key":"4097_CR34","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3892\/etm.2016.3862","volume":"12","author":"M Ogawa","year":"2016","unstructured":"Ogawa M et al (2016) Effects of oral intake of heat-killed Lactobacillus brevis SBC8803 (SBL88\u2122) on dry skin conditions: a randomized, double-blind, placebo-controlled study. Exp Ther Med 12(6):3863\u20133872. https:\/\/doi.org\/10.3892\/etm.2016.3862","journal-title":"Exp Ther Med"},{"issue":"6","key":"4097_CR35","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00403-023-02553-1","volume":"315","author":"ES Suriano","year":"2023","unstructured":"Suriano ES, Souza MDM, Kobata CM, Santos FHY, Mimica MJ (2023) Efficacy of an adjuvant Lactobacillus rhamnosus formula in improving skin lesions as assessed by PASI in patients with plaque psoriasis from a university-affiliated, tertiary-referral hospital in S\u00e3o Paulo (Brazil): a parallel, double-blind, randomized clinical trial. Arch Dermatol Res 315(6):1621\u20131629. https:\/\/doi.org\/10.1007\/s00403-023-02553-1","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"4097_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gtc.2016.09.012","volume":"46","author":"SM Vindigni","year":"2017","unstructured":"Vindigni SM, Surawicz CM (2017) Fecal microbiota transplantation. Gastroenterol Clin North Am 46(1):171\u2013185. https:\/\/doi.org\/10.1016\/j.gtc.2016.09.012","journal-title":"Gastroenterol Clin North Am"},{"key":"4097_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.964154","author":"B Zou","year":"2022","unstructured":"Zou B et al (2022) Long-term safety and efficacy of fecal microbiota transplantation in 74 children: a single-center retrospective study. Front Pediatr. https:\/\/doi.org\/10.3389\/fped.2022.964154","journal-title":"Front Pediatr."},{"key":"4097_CR38","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.2147\/JIR.S337031","volume":"14","author":"H-L Chen","year":"2021","unstructured":"Chen H-L et al (2021) Gut and cutaneous microbiome featuring abundance of lactobacillus reuteri protected against psoriasis-like inflammation in mice. J Inflamm Res 14:6175\u20136190. https:\/\/doi.org\/10.2147\/JIR.S337031","journal-title":"J Inflamm Res"},{"issue":"10","key":"4097_CR39","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3760\/cma.j.issn.0578-1426.2019.10.011","volume":"58","author":"G Yin","year":"2019","unstructured":"Yin G et al (2019) Fecal microbiota transplantation as a novel therapy for severe psoriasis. Zhonghua Nei Ke Za Zhi 58(10):782\u2013785. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2019.10.011","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"4097_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.celrep.2018.12.028","volume":"26","author":"K Wang","year":"2019","unstructured":"Wang K et al (2019) Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep 26(1):222-235.e5. https:\/\/doi.org\/10.1016\/j.celrep.2018.12.028","journal-title":"Cell Rep"},{"issue":"8","key":"4097_CR41","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1002\/eji.201546263","volume":"46","author":"K Stelzner","year":"2016","unstructured":"Stelzner K et al (2016) Free fatty acids sensitize dendritic cells to amplify TH1\/TH17-immune responses. Eur J Immunol 46(8):2043\u20132053. https:\/\/doi.org\/10.1002\/eji.201546263","journal-title":"Eur J Immunol"},{"key":"4097_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01219-0","author":"Q Zhao","year":"2023","unstructured":"Zhao Q et al (2023) Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-022-01219-0","journal-title":"Signal Transduct Target Ther."},{"key":"4097_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01162","author":"VK Gupta","year":"2017","unstructured":"Gupta VK, Paul S, Dutta C (2017) Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Front Media SA. https:\/\/doi.org\/10.3389\/fmicb.2017.01162","journal-title":"Front Media SA"},{"key":"4097_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.662047","author":"AL Carvalho","year":"2021","unstructured":"Carvalho AL, Hedrich CM (2021) The molecular pathophysiology of psoriatic arthritis\u2014the complex interplay between genetic predisposition, epigenetics factors, and the microbiome. Front Media SA. https:\/\/doi.org\/10.3389\/fmolb.2021.662047","journal-title":"Front Media SA"},{"key":"4097_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humic.2018.01.001","volume":"7\u20138","author":"B Senghor","year":"2018","unstructured":"Senghor B, Sokhna C, Ruimy R, Lagier J-C (2018) Gut microbiota diversity according to dietary habits and geographical provenance. Hum Microb J 7\u20138:1\u20139. https:\/\/doi.org\/10.1016\/j.humic.2018.01.001","journal-title":"Hum Microb J"},{"key":"4097_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11072015","author":"C Stolfi","year":"2023","unstructured":"Stolfi C, Pacifico T, Monteleone G, Laudisi F (2023) Impact of western diet and ultra-processed food on the intestinal mucus barrier. Multidiscip Dig Pub Inst. https:\/\/doi.org\/10.3390\/biomedicines11072015","journal-title":"Multidiscip Dig Pub Inst"},{"key":"4097_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158250","author":"C Munteanu","year":"2024","unstructured":"Munteanu C, Schwartz B (2024) Interactions between dietary antioxidants dietary fiber and the gut microbiome: their putative role in inflammation and cancer. Multidiscipl Dig Pub Inst. https:\/\/doi.org\/10.3390\/ijms25158250","journal-title":"Multidiscipl Dig Pub Inst"},{"issue":"4","key":"4097_CR48","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/1541-4337.12563","volume":"19","author":"YT Loo","year":"2020","unstructured":"Loo YT, Howell K, Chan M, Zhang P, Ng K (2020) Modulation of the human gut microbiota by phenolics and phenolic fiber-rich foods. Compr Rev Food Sci Food Saf 19(4):1268\u20131298. https:\/\/doi.org\/10.1111\/1541-4337.12563","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"2","key":"4097_CR49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19(2):275\u2013293. https:\/\/doi.org\/10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"key":"4097_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101587","author":"J Yoo","year":"2020","unstructured":"Yoo J, Groer M, Dutra SVO, Sarkar A, McSkimming DI (2020) Gut microbiota and immune system interactions. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms8101587","journal-title":"Microorganisms"},{"issue":"6","key":"4097_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/pathogens9060463","volume":"9","author":"M Sikora","year":"2020","unstructured":"Sikora M et al (2020) Gut microbiome in psoriasis: an updated review. Pathogens 9(6):463. https:\/\/doi.org\/10.3390\/pathogens9060463","journal-title":"Pathogens"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04097-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04097-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04097-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:00:51Z","timestamp":1741798851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04097-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4097"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04097-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"561"}}